Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Patil

Showing results (231-240 of 242) with videos related to

Pageof 25
Sort By:
Genome Research|September 8, 2017
Toward the human cellular microRNAomeMatthew N McCall, Min-Sik Kim, Mohammed Adil, et al.
Oncotarget|August 20, 2016
Chronic exposure to cigarette smoke leads to activation of p21 (RAC1)-activated kinase 6 (PAK6) in non-small cell lung cancer cellsRemya Raja, Nandini A Sahasrabuddhe, Aneesha Radhakrishnan, et al.
Scientific Reports|December 13, 2019
MAP2K1 is a potential therapeutic target in erlotinib resistant head and neck squamous cell carcinomaAnkit P Jain, Krishna Patel, Sneha Pinto, et al.
BMC Cancer|November 5, 2015
Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancerTejaswini Subbannayya, Pamela Leal-Rojas, Mustafa A Barbhuiya, et al.
Oncoscience|September 30, 2021
Correction: Targeting focal adhesion kinase overcomes erlotinib resistance in smoke induced lung cancer by altering phosphorylation of epidermal growth factor receptorHitendra S Solanki, Remya Raja, Alex Zhavoronkov, et al.
Journal of Cell Communication and Signaling|January 23, 2019
PIM1 kinase promotes gallbladder cancer cell proliferation via inhibition of proline-rich Akt substrate of 40 kDa (PRAS40)Tejaswini Subbannayya, Pamela Leal-Rojas, Alex Zhavoronkov, et al.
Oncoscience|March 21, 2018
Targeting focal adhesion kinase overcomes erlotinib resistance in smoke induced lung cancer by altering phosphorylation of epidermal growth factor receptorHitendra S Solanki, Remya Raja, Alex Zhavoronkov, et al.
JAMA Oncology|May 19, 2017
Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate CancerMartin G Sanda, Ziding Feng, David H Howard, et al.
Research Square|August 16, 2024
Neoadjuvant cabozantinib restores CD8+ T cells in patients with locally advanced non-metastatic clear cell renal cell carcinoma: a phase 2 trialMehmet A Bilen, BaoHan T Vo, Yuan Liu, et al.
Nature Cancer|February 27, 2025
Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trialMehmet A Bilen, BaoHan T Vo, Yuan Liu, et al.
Pageof 25

Showing results (231-240 of 242) with videos related to

Sort By:
Pageof 25
Genome Research|September 8, 2017
Toward the human cellular microRNAomeMatthew N McCall, Min-Sik Kim, Mohammed Adil, et al.
Oncotarget|August 20, 2016
Chronic exposure to cigarette smoke leads to activation of p21 (RAC1)-activated kinase 6 (PAK6) in non-small cell lung cancer cellsRemya Raja, Nandini A Sahasrabuddhe, Aneesha Radhakrishnan, et al.
Scientific Reports|December 13, 2019
MAP2K1 is a potential therapeutic target in erlotinib resistant head and neck squamous cell carcinomaAnkit P Jain, Krishna Patel, Sneha Pinto, et al.
BMC Cancer|November 5, 2015
Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancerTejaswini Subbannayya, Pamela Leal-Rojas, Mustafa A Barbhuiya, et al.
Oncoscience|September 30, 2021
Correction: Targeting focal adhesion kinase overcomes erlotinib resistance in smoke induced lung cancer by altering phosphorylation of epidermal growth factor receptorHitendra S Solanki, Remya Raja, Alex Zhavoronkov, et al.
Journal of Cell Communication and Signaling|January 23, 2019
PIM1 kinase promotes gallbladder cancer cell proliferation via inhibition of proline-rich Akt substrate of 40 kDa (PRAS40)Tejaswini Subbannayya, Pamela Leal-Rojas, Alex Zhavoronkov, et al.
Oncoscience|March 21, 2018
Targeting focal adhesion kinase overcomes erlotinib resistance in smoke induced lung cancer by altering phosphorylation of epidermal growth factor receptorHitendra S Solanki, Remya Raja, Alex Zhavoronkov, et al.
JAMA Oncology|May 19, 2017
Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate CancerMartin G Sanda, Ziding Feng, David H Howard, et al.
Research Square|August 16, 2024
Neoadjuvant cabozantinib restores CD8+ T cells in patients with locally advanced non-metastatic clear cell renal cell carcinoma: a phase 2 trialMehmet A Bilen, BaoHan T Vo, Yuan Liu, et al.
Nature Cancer|February 27, 2025
Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trialMehmet A Bilen, BaoHan T Vo, Yuan Liu, et al.
Pageof 25